AwardedPOLGoods
Sukcesywne dostawy leku dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej-Curie - Państwowego Instytutu Badawczego Oddziału w Gliwicach
- Published
- Published 28 May 2026
Overview
The National Institute of Oncology in Gliwice awarded successive drug supplies to a consortium comprising Urtica Sp. z o.o., Bristol Myers Squibb Polska Sp. z o.o., and Roche Polska Sp. z o.o. for a value of 1,298,160 PLN. The contract, awarded on 26 May 2026, provides for successive deliveries over four months or until the financial limit is exhausted, whichever occurs first.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 28 May 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 1,298,160
- Award date
- 26 May 2026
- Contract period
- — → 23 September 2026
- Konsorcjum firm: Urtica Sp. z o.o. ul. Krzemieniecka 120, 54-613 Wrocław i Bristol Myers Squibb Polska Sp. z o.o. ul. Armii Ludowej 26, 00-609 Warszawa
- Roche Polska Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
4 June 2026
Contract Notice
29 May 2026
Contract Notice
28 May 2026
Contracting authority
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach
Procuring entityGliwice, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.